Back to Authors

Davis, Thomas A.

Mayo Clinic

Celldex Therapeutics (United States)

Citations 1

Phase I evaluation of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies.
Ansell, Stephen M. , Northfelt, Donald W. , Burris, Howard A. , Dinner, Shira, Villalobos, Víctor M. , Šikić, Branimir I. , Pilja, Lana, Hawthorne, Thomas, Keler, Tibor , Davis, Thomas A., Flinn, Ian W. , Taylor, Matthew H. , Yellin, Michael , Davis, Thomas A.

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 3024-3024

10.1200/jco.2014.32.15_suppl.3024 Get It